Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Alfonso Gómez Iturriaga"'
Autor:
Almudena Zapatero, Pablo Castro, María Roch, Pablo Rodríguez Carnero, Sara Carroceda, Alexandra Elena Stoica Rosciupchin, Sergio Honorato Hernández, Leopoldo Cogorno, Alfonso Gómez Iturriaga, David Büchser García
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background Stereotactic ablative body radiotherapy (SABR) is an emerging treatment alternative for patients with localized low and intermediate risk prostate cancer patients. As already explored by some authors in the context of conventional
Externí odkaz:
https://doaj.org/article/c340109435924554bc9fb0ab47537450
Autor:
Maria Antonia Gómez-Aparicio, Jeannette Valero, Begoña Caballero, Rafael García, Ovidio Hernando-Requejo, Ángel Montero, Alfonso Gómez-Iturriaga, Thomas Zilli, Piet Ost, Fernando López-Campos, Felipe Couñago
Publikováno v:
Current Oncology, Vol 28, Iss 4, Pp 2933-2949 (2021)
Prostate cancer is the most commonly diagnosed cancer among men around the world. Radiotherapy is a standard of care treatment option for men with localized prostate cancer. Over the years, radiation delivery modalities have contributed to increased
Externí odkaz:
https://doaj.org/article/444437458baf4aef91542c241b067dcc
Autor:
Pedro C. Lara, Juan I. Rodríguez-Melcón, Amalia Palacios-Eito, Antonio Lozano, Asunción Hervás-Morón, Elena Villafranca, Alfonso Gómez-Iturriaga, Gemma Sancho, Xavier Maldonado
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundIntermediate-risk prostate cancer (PCa) is usually treated by a combination of external beam radiation therapy (EBRT) and a short course of androgen deprivation therapy (ADT). ADT is associated with multiple side effects, including weight g
Externí odkaz:
https://doaj.org/article/c70f8a99ebe74f68bb2aca7108584a78
Autor:
Esther Mayrata, Jose Maria Espinosa, David Büchser, Francisco Casquero, Fernan Suárez, Alba González, Pablo Minguez, Jose Fernando Pérez, Iñigo San Miguel, Jon Cacicedo, Alfonso Gómez-Iturriaga
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 13, Iss 1, Pp 12-17 (2021)
Externí odkaz:
https://doaj.org/article/0811dabbebeb452a98b1ab0b4485cc51
Autor:
Jon, Cacicedo, Francisco, Casquero, Arturo, Navarro, Lorea, Martinez-Indart, Olga, Del Hoyo, Andere, Frías, Roberto Ortiz, de Zarate, David, Büchser, Alfonso, Gómez-Iturriaga, Iñigo, San Miguel, Fernan, Suarez, Adrian, Barcena, Jose Luis, López-Guerra
Publikováno v:
BJR|Open. 4
Objective: To analyse patterns of treatment with curative intent commonly used in elderly patients with locally advanced non-small-cell lung carcinoma (NSCLC) and predictive factors of overall survival in routine clinical practice. Methods: This mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89ef651f3e3170df33d63057c29fba22
https://doi.org/10.1259/bjro.20210058
https://doi.org/10.1259/bjro.20210058
Publikováno v:
In Brachytherapy 2010 9(3):213-218
Publikováno v:
Urology. 75:1412-1416
Objectives To report the genitourinary (GU) and gastrointestinal (GI) toxicity rates, erectile function preservation, and biochemical outcome (bNED) in men aged ≤ 55 years treated with 125 iodine ( 125 I) brachytherapy (BT). Methods Between May 199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1996707bc5cafddea17b20f3a7303229
https://doi.org/10.1016/j.urology.2009.04.101
https://doi.org/10.1016/j.urology.2009.04.101
Autor:
Eduardo, Hortelano, Alfonso, Gómez-Iturriaga, Roberto, Ortiz-de-Zárate, Manuel, Zaballa, Ángel, Barturen, Francisco, Casquero, Íñigo, San-Miguel, Carvajal, Carvajal, Jon, Cacicedo, Olga, Del-Hoyo, Javier, Lupiani, Fernando, Pérez, Pedro, Bilbao
Publikováno v:
Revista Española de Enfermedades Digestivas v.106 n.3 2014
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Revista Espanola de Enfermedades Digestivas, Vol 106, Iss 3, Pp 165-170
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Revista Espanola de Enfermedades Digestivas, Vol 106, Iss 3, Pp 165-170
Introduction: In severe cases refractory to medical treatment, APC appears to be the preferred alternative to control persistent rectal bleeding of patients with chronic radiation proctitis. Although successful outcomes have been demonstrated in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6782f6db882f6b9aa2e12f65e0264e23
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082014000300003
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082014000300003
Autor:
Eduardo Hortelano, Alfonso Gómez-Iturriaga, Roberto Ortiz-de-Zárate, Manuel Zaballa, Ángel Barturen, Francisco Casquero, Íñigo San-Miguel, Claudia Carvajal, Jon Cacicedo, Olga del Hoyo, Javier Lupiani, Fernando Pérez, Pedro Bilbao
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 106, Iss 3, Pp 165-170
Introduction: In severe cases refractory to medical treatment, APC appears to be the preferred alternative to control persistent rectal bleeding of patients with chronic radiation proctitis. Although successful outcomes have been demonstrated in pati
Externí odkaz:
https://doaj.org/article/8b8fa29ecb284fc087f28cba38990f13
Publikováno v:
International journal of radiation oncology, biology, physics. 78(2)
Purpose Iodine-125 ( 125 I) prostate brachytherapy is planned with a prescribed dose of 145 Gy and minimal dose received by 90% of the prostate (D 90 ) of 120–125% (174–181 Gy). We examined the clinical outcomes and toxicity profile of men receiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39759dcb8cd9f86ad1c7c5f8e9f37de
https://pubmed.ncbi.nlm.nih.gov/20832665
https://pubmed.ncbi.nlm.nih.gov/20832665